Page last updated: 2024-10-25

eflornithine and Multiple Primary Neoplasms

eflornithine has been researched along with Multiple Primary Neoplasms in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halberg, RB1
Katzung, DS1
Hoff, PD1
Moser, AR1
Cole, CE1
Lubet, RA1
Donehower, LA1
Jacoby, RF1
Dove, WF1
Rao, CV1
Tokumo, K1
Rigotty, J1
Zang, E1
Kelloff, G1
Reddy, BS1

Other Studies

2 other studies available for eflornithine and Multiple Primary Neoplasms

ArticleYear
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Mar-28, Volume: 97, Issue:7

    Topics: Adenoma; Animals; Eflornithine; Female; Fibromatosis, Aggressive; Genes, APC; Genes, p53; Intestinal

2000
Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
    Cancer research, 1991, Sep-01, Volume: 51, Issue:17

    Topics: Animals; Body Weight; Colonic Neoplasms; Dehydroepiandrosterone; Drug Combinations; Drug Evaluation,

1991